| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0002-9343(83)91075-6 |
| P698 | PubMed publication ID | 6837607 |
| P2093 | author name string | M Shaw | |
| J B Winfield | |||
| R A Eisenberg | |||
| L M Silverman | |||
| D Koffler | |||
| H A Wilson | |||
| P433 | issue | 5 | |
| P921 | main subject | nervous system | Q9404 |
| systemic lupus erythematosus | Q1485 | ||
| lupus erythematosus | Q188297 | ||
| blood–brain barrier | Q221694 | ||
| P304 | page(s) | 837-844 | |
| P577 | publication date | 1983-05-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction | |
| P478 | volume | 74 |
| Q48660819 | A study of immune responses to myelin and cardiolipin in patients with systemic lupus erythematosus (SLE). |
| Q37548266 | Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study |
| Q34240254 | Activation of type I interferon pathway in systemic lupus erythematosus: association with distinct clinical phenotypes |
| Q54527697 | Association between serum IgG antibodies to recombinant ribosomal P0 fusion protein and neuropsychiatric systemic lupus erythematosus. |
| Q34374733 | Association of cerebrospinal fluid anti-Sm antibodies with acute confusional state in systemic lupus erythematosus |
| Q36392326 | Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q33706403 | Barrier dysfunction or drainage reduction: differentiating causes of CSF protein increase. |
| Q37058781 | Biomarkers in systemic lupus erythematosus: challenges and prospects for the future |
| Q67548602 | Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia |
| Q33765429 | Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q30523821 | CCL2 disrupts the adherens junction: implications for neuroinflammation |
| Q41002727 | Central nervous system (CNS) involvement in SLE. The diagnostic role of antibodies to neuronal antigens |
| Q33584052 | Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy |
| Q39831064 | Cerebral disease in systemic lupus erythematosus |
| Q33621338 | Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus |
| Q43872604 | Cerebrospinal fluid: electrophoresis and methods for determining immunoglobulin G compared |
| Q33628713 | Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus |
| Q24793525 | Decreased levels of soluble amyloid beta-protein precursor and beta-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus |
| Q41524233 | Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling |
| Q33217667 | Elevated immunoglobulin levels in the cerebrospinal fluid from lupus-prone mice |
| Q42695876 | Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus |
| Q39579269 | Failure of interferon alfa and tribavirin in rabies encephalitis |
| Q48423132 | Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus |
| Q39507052 | Immunopathogenesis of the neuropsychiatric manifestations of systemic lupus erythematosus |
| Q33564647 | Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum |
| Q34790180 | Interferon alpha (IFNalpha) and psychiatric syndromes: a review |
| Q24798439 | Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement |
| Q28268802 | Lupus brain fog: a biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus |
| Q36707992 | Neuroimmunopathology in a murine model of neuropsychiatric lupus |
| Q40469520 | Neuropsychiatric Manifestations of Systemic Lupus Erythematosus |
| Q71933430 | Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests |
| Q42153615 | Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system |
| Q37351240 | Potent induction of IFN-alpha and chemokines by autoantibodies in the cerebrospinal fluid of patients with neuropsychiatric lupus |
| Q39579274 | Rapid diagnosis of rabies and post-vaccinal encephalitides |
| Q81462541 | Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus |
| Q40572101 | Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus |
| Q33562546 | Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus |
| Q39756290 | Systemic lupus erythematosus clinical issues |
| Q68080217 | Systemic lupus erythematosus presenting with neurological disorders |
| Q37930475 | Systemic lupus erythematosus, the brain, and anti-NR2 antibodies |
| Q40371891 | Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction |
| Q35688684 | TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. |
| Q30476952 | The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus |
| Q33926168 | Transgenic models for cytokine-induced neurological disease |
| Q79861903 | [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters] |
Search more.